A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2001
10/23/2001	CA1341308C Vaccines against avian herpes viruses
10/23/2001	CA1341307C Nucleotide sequences of avian herpes viruses
10/23/2001	CA1341306C Yeast expression of urokinase-type plasminogen activator and mutants thereof
10/20/2001	CA2304494A1 A novel heteromultimeric ion channel receptor and uses thereof
10/18/2001	WO2001077687A2 Prion-binding peptidic ligands and methods of using same
10/18/2001	WO2001077673A1 Hypotensors
10/18/2001	WO2001077389A2 Genes expressed in foam cell differentiation
10/18/2001	WO2001077361A1 Human immunoglobulin-producing gnotobiotics
10/18/2001	WO2001077358A2 Herpes viruses for immune modulation
10/18/2001	WO2001077341A2 Mammalian heparanase
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077336A2 Acyl-coa dehydrogenase mutant and uses thereof
10/18/2001	WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	WO2001077332A2 Compositions and methods related to canine igg and canine il-13 receptors
10/18/2001	WO2001077331A1 Human trp-like calcium channel protein-2 (tlcc-2)
10/18/2001	WO2001077330A2 G protein-coupled receptors
10/18/2001	WO2001077329A2 Human twik molecules and uses thereof
10/18/2001	WO2001077328A1 Methods of using growth factors for treating heart disease
10/18/2001	WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001	WO2001077326A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof
10/18/2001	WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof
10/18/2001	WO2001077320A2 Regulation of human hm74-like g protein coupled receptor
10/18/2001	WO2001077318A1 Regulatory element from a sugarcane proline rich protein and uses thereof
10/18/2001	WO2001077309A2 Crystallization and structure determination of staphylococcus aureus thioredoxin reductase
10/18/2001	WO2001077308A1 A new polypeptide - human quinone reductase 18 and the polynucleotide encoding it
10/18/2001	WO2001077294A2 Hpv-specific short-mers
10/18/2001	WO2001077290A2 Polynucleotides encoding novel secreted proteins
10/18/2001	WO2001077289A2 Polynucleotides encoding novel secreted proteins
10/18/2001	WO2001077286A2 A novel polypeptide, human uterine globine 58 and the polynucleotide encoding the polypeptide
10/18/2001	WO2001077177A2 Gpcr-proteins and nucleic acids encoding same
10/18/2001	WO2001077175A2 G protein-coupled receptors
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077173A1 Tm4sf receptor polynucleotides, polypeptides, and antibodies
10/18/2001	WO2001077172A2 Non-endogenous, constitutively activated known g protein-coupled receptors
10/18/2001	WO2001077171A2 Soluble zalpha11 cytokine receptors
10/18/2001	WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077168A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/18/2001	WO2001077167A2 Methods of investigating, diagnosing, and treating amyloidosis
10/18/2001	WO2001077166A1 Novel physiologically active peptides and use thereof
10/18/2001	WO2001077165A1 A novel polypeptide, human amyloid precursor protein-binding protein 12 and the polynucleotide encoding thereof
10/18/2001	WO2001077163A1 A novel polypeptide-human cell differenciation transcription factor 16 and the polynucleotide encoding said polypeptide
10/18/2001	WO2001077160A1 A modified h-ns peptide of salmonella typhimurium, capable of modulating the oligomerization of h-ns
10/18/2001	WO2001077158A1 Hepatitis b core antigen fusion proteins
10/18/2001	WO2001077155A2 Orfx polynucleotides and polypeptides
10/18/2001	WO2001077152A2 Mammalian disulfide core protein-4
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077146A2 Compounds and methods for modulating endothelial cell adhesion
10/18/2001	WO2001077145A2 Integrin binding peptide derivatives
10/18/2001	WO2001077144A1 Gamma-secretase inhibitors
10/18/2001	WO2001077141A1 Shock heat treatment of polypeptides
10/18/2001	WO2001077137A1 Albumin fusion proteins
10/18/2001	WO2001077136A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia
10/18/2001	WO2001077114A1 Inhibitors of prenyl-protein transferase
10/18/2001	WO2001077113A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties
10/18/2001	WO2001076662A1 Adsorbents for dilated cardiomyopathy
10/18/2001	WO2001076654A1 Methods and compositions for treating intervertebral disc degeneration
10/18/2001	WO2001076650A1 Compositions and methods for promoting wound healing
10/18/2001	WO2001076649A1 An injectable bone mineral substitute material
10/18/2001	WO2001076644A2 Lipid-based systems for targeting diagnostic agents
10/18/2001	WO2001076640A2 Chemically modified novel erythropoietin stimulating protein compositions and methods
10/18/2001	WO2001076639A2 Chemically-modified myelopoietin conjugates
10/18/2001	WO2001076638A2 Compositions for drug delivery
10/18/2001	WO2001076637A2 Peptide conjugates for drug delivery
10/18/2001	WO2001076636A2 Pharmaceutical composition of modified pna molecules
10/18/2001	WO2001076632A1 Formulation for the prevention of cardiovascular disease
10/18/2001	WO2001076631A2 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia
10/18/2001	WO2001076627A1 Treatment of fungal infections with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
10/18/2001	WO2001076622A2 Immunogenic peptides derived from prostate-specific antigen (psa) and uses thereof
10/18/2001	WO2001076621A2 Methods and compositions for treating neoplasms
10/18/2001	WO2001076620A2 Use of vegf and homologues to treat neuron disorders
10/18/2001	WO2001076619A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
10/18/2001	WO2001076618A1 Mechanically activated channel blocker
10/18/2001	WO2001076617A2 Oral tolerance induction by collagen to prevent allograft rejection
10/18/2001	WO2001076616A1 Tamandarin and didemnin analogs and methods of making and using them
10/18/2001	WO2001076615A2 Cxcr4 agonist treatment of hematopoietic cells
10/18/2001	WO2001076586A1 Combination product comprising a non-steroidal antiandrogen and an egfr tyrosine kinase inhibitor
10/18/2001	WO2001076575A2 The treatment of respiratory diseases
10/18/2001	WO2001076573A2 Combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
10/18/2001	WO2001076567A1 Method and composition for treating cancer by administration of apoptosis-inducing chemotherapeutic agents
10/18/2001	WO2001076561A2 Pharmaceutical compositions
10/18/2001	WO2001076558A1 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix
10/18/2001	WO2001076556A2 Lipid-based drug delivery systems against parasitic infections
10/18/2001	WO2001076555A2 Lipid-based drug delivery systems for topical application
10/18/2001	WO2001076538A1 Compositions for metabolic protection and repair of lips
10/18/2001	WO2001076381A1 Protein stabilised emulsions
10/18/2001	WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001	WO2001063293A8 Diagnosis and treatment of schizophrenia
10/18/2001	WO2001040313A3 Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
10/18/2001	WO2001038352A3 Methods of inhibiting metastasis
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001035901A3 Use of enzymes for skin expansion
10/18/2001	WO2001032832A3 Antisense inhibition of nucleolin expression
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001026683A3 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses
10/18/2001	WO2001025435A3 In vivo treatment of joint disease using interleukin-1 receptor antagonists
10/18/2001	WO2001025264A3 Substituted phosphinate based peptide derivatives
10/18/2001	WO2001024817A3 Pharmaceutical compositions of fibrinolytic agent
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof

1 ... 2177 2178 2179 2180 2181 2182 2183 2184 2185 2186 2187 2188 2189 2190 2191 2192 2193 2194 2195 2196 2197 ... 3163